Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 May;21(5):852–854. doi: 10.1128/aac.21.5.852

Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis.

D A Stevens, P T Vo
PMCID: PMC182028  PMID: 7103462

Abstract

The in vitro interaction of trimethoprim and sulfamethoxazole on clinical isolates of Paracoccidioides brasiliensis was studied. With complete inhibition and a visual endpoint used as the criteria, three of four strains had minimal inhibitory concentrations that indicated resistance to sulfamethoxazole, and all four strains were resistant to trimethoprim. A marked synergism in inhibition was noted with the combination of these drugs against sulfa-resistant strains. A sulfamethoxazole/trimethoprim ratio of 5:1 was the most synergistic. Fifty percent inhibition, determined spectrophotometrically, of the strains could be achieved with sulfamethoxazole alone. In summary, the striking synergy observed suggests that combination chemotherapy with these drugs deserves further study.

Full text

PDF
852

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin T. W., Holmes K. K. The use of trimethoprim-sulfamethoxazole in gonococcal infections. Can Med Assoc J. 1975 Jun 14;112(13 Spec No):37–39. [PMC free article] [PubMed] [Google Scholar]
  2. Bennett J. E., Jennings A. E. Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1978 Apr;13(4):624–627. doi: 10.1128/aac.13.4.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bushby S. R. Sensitivity testing with trimethorpim-sulphamethoxazole. Med J Aust. 1973 Jun 30;1(2 Suppl):10–18. [PubMed] [Google Scholar]
  4. ELION G. B., SINGER S., HITCHINGS G. H. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J Biol Chem. 1954 Jun;208(2):477–488. [PubMed] [Google Scholar]
  5. Feldman H. A. Effects of trimethoprim and sulfisoxazole, alone and in combination, on growth and carriage of Neisseria meningitidis. J Infect Dis. 1973 Nov;128(Suppl):723–p. doi: 10.1093/infdis/128.supplement_3.s723. [DOI] [PubMed] [Google Scholar]
  6. Fountain F. F., Sutliff W. D. Paracoccidioidomycosis in the United States. Am Rev Respir Dis. 1969 Jan;99(1):89–93. doi: 10.1164/arrd.1969.99.1.89. [DOI] [PubMed] [Google Scholar]
  7. Galgiani J. N., Stevens D. A. Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. Antimicrob Agents Chemother. 1976 Oct;10(4):721–728. doi: 10.1128/aac.10.4.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kaplan S. A., Weinfeld R. E., Abruzzo C. W., McFaden K., Jack M. L., Weissman L. Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man. J Infect Dis. 1973 Nov;128(Suppl):547–p. doi: 10.1093/infdis/128.supplement_3.s547. [DOI] [PubMed] [Google Scholar]
  9. Lawrence A., Phillips I., Nicol C. Various regimens of trimethoprim-sulfamethoxazole used in the treatment of gonorrhea. J Infect Dis. 1973 Nov;128(Suppl):673–p. doi: 10.1093/infdis/128.supplement_3.s673. [DOI] [PubMed] [Google Scholar]
  10. Lopes C. F., Armond S. Ensaio terapêutico em casos sulfa-resistentes de blastomicose sul-americana. Hospital (Rio J) 1968 Apr;73(4):1245–1255. [PubMed] [Google Scholar]
  11. Murray H. W., Littman M. L., Roberts R. B. Disseminated paracoccidioidomycosis (South American blastomycosis) in the United States. Am J Med. 1974 Feb;56(2):209–220. doi: 10.1016/0002-9343(74)90599-3. [DOI] [PubMed] [Google Scholar]
  12. Restrepo A., Arango M. D. In vitro susceptibility testing of Paracoccidioides brasiliensis to sulfonamides. Antimicrob Agents Chemother. 1980 Jul;18(1):190–194. doi: 10.1128/aac.18.1.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Restrepo A., Jiménez B. E. Growth of Paracoccidioides brasiliensis yeast phase in a chemically defined culture medium. J Clin Microbiol. 1980 Aug;12(2):279–281. doi: 10.1128/jcm.12.2.279-281.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Restrepo A., Robledo M., Giraldo R., Hernández H., Sierra F., Gutiérrez F., Londoño F., López R., Calle G. The gamut of paracoccidioidomycosis. Am J Med. 1976 Jul;61(1):33–42. doi: 10.1016/0002-9343(76)90028-0. [DOI] [PubMed] [Google Scholar]
  15. Restrepo A., Robledo M., Gutiérrez F., Sanclemente M., Castañeda E., Calle G. Paracoccidioidomycosis, (South American blastomycosis). A study of 39 cases observed in Medellin, Colombia. Am J Trop Med Hyg. 1970 Jan;19(1):68–76. [PubMed] [Google Scholar]
  16. Restrepo A., Stevens D. A., Gómez I., Leiderman E., Angel R., Fuentes J., Arana A., Mejía G., Vanegas A. C., Robledo M. Ketoconazole: a new drug for the treatment of paracoccidioidomycosis. Rev Infect Dis. 1980 Jul-Aug;2(4):633–642. doi: 10.1093/clinids/2.4.633. [DOI] [PubMed] [Google Scholar]
  17. Rubin R. H., Swartz M. N. Trimethoprim-sulfamethoxazole. N Engl J Med. 1980 Aug 21;303(8):426–432. doi: 10.1056/NEJM198008213030804. [DOI] [PubMed] [Google Scholar]
  18. Scholer H. J. Sulfonamides in experimental nocardiosis, histoplasmosis, and South American blastomycosis. Chemotherapy. 1968;13(2):65–80. doi: 10.1159/000220533. [DOI] [PubMed] [Google Scholar]
  19. Stevens D. A. Drugs for systemic fungal infections. Ration Drug Ther. 1979 May;13(5):1–7. [PubMed] [Google Scholar]
  20. Stevens D. A., Restrepo-M A., Cortés A., Betancourt J., Galgiani J. N., Gómez I. Paracoccidioidomycosis (South American blastomycosis): treatment with miconazole. Am J Trop Med Hyg. 1978 Jul;27(4):801–807. doi: 10.4269/ajtmh.1978.27.801. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES